TOVX

$0.18-1.09%visit website

Theriva Biologics, Inc.

Market Cap

$8M

Live price × SEC shares (Aug 7, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.26

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.7

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue			300	0
Research & development	2,551	1,132	355	1,268	5,306
Total operating expenses	4,440	2,063	2,427	3,295	12,225
Operating income	(4,440)	(2,063)	(2,127)	(3,295)	(11,925)
Interest expense			16.0	17.0
Pretax income	(4,361)	(1,996)	(2,044)	(3,217)	(11,618)
Net income	(4,361)	(3,506)	(2,044)	(3,217)	(13,128)
EPS (basic) ($)	(0.45)		(0.05)	(0.07)	—
EPS (diluted) ($)	(0.45)		(0.05)	(0.07)	—
Weighted avg. shares (basic)	9,677		41,073	45,893
Weighted avg. shares (diluted)	9,677		41,073	45,893

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 11, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

18 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 4:05 PM ET	1.01Material agreement2.01Acquisition / disposition7.01Reg FD disclosure	Document SEC ↗
Aug 11, 2026 accepted 8:10 AM ET	2.02Earnings release	Document SEC ↗
Aug 6, 2026 accepted 8:10 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Aug 4, 2026 accepted 7:20 AM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Jul 7, 2026 accepted 8:10 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 11, 2026 accepted 8:10 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 5, 2026 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
May 5, 2026 accepted 4:35 PM ET	2.02Earnings release	Document SEC ↗
Apr 17, 2026 accepted 4:15 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Apr 9, 2026 accepted 4:15 PM ET	8.01Other events	Document SEC ↗